Searchable abstracts of presentations at key conferences in endocrinology

ea0020p83 | Thyroid | ECE2009

The role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodule

Castells Ignasi , Pardo Nuria , Gimenez Gabriel , Simo Olga , Recasens Asumpta , Franch Guzman , Guirao Xavier , Serrano Angel

Introduction: In 2004, the multidisciplinary thyroid nodule committee of our centre adopted the cytological classification from the British Thyroid Association for reporting fine-needle aspiration biopsy (FNAB) results and agreed about its proper management: Thy1, inadequate sample, repeat FNAB. Thy2, benign; follow up, repeat FNAB if nodule growth; Thy3 indeterminate or follicular lesions; surgery or repeat FNAB at 6 months if low clinical, sonographic or cytologyc suspicious...

ea0020p101 | Thyroid | ECE2009

Thyroid node pathology: correlation between cytology, histology and radiology using a new cytological classification

Castells Ignasi , Pardo Nuria , Franch Guzman , Simo Olga , Recasens Asumpta , Guirao Xavier , Gimenez Gabriel

Introduction: A modification of the cytological classification from the ‘British Thyroid Association – Royal College of Physicians’ has been adapted for reporting fine-needle-puncture (FNP) cytology results since 2004 (Thy score). Five diagnostic categories have been agreed by our multidisciplinary committee: Thy1, inadequate sample; Thy2, benign; Thy3 indeterminate; Thy4, suspicious; Thy5, malignant.Aim: Evaluate the correlation between c...

ea0032p868 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

Sesmilo Gemma , Resmini Eugenia , Bernabeu Ignacio , Aller Javier , Soto Alfonso , Marazuela Monica , Mora Mireia , Pico Antonio , Fajardo Carmen , Torres Elena , Alvarez-Escola Cristina , Garcia-Centeno Rogelio , Blanco Concepcion , Camara Rosa , Gaztambide Sonia , Salinas Isabel , Del Pozo Carlos , Castells Ignasi , Villabona Carles , Webb Susan

Pegvisomant (peg) is an effective treatment for acromegaly.Aim: To investigate the prevalence of escape and the incidence of lipodystrophy with peg treatment.Methods: Multicenter retrospective study. Escape was defined as loss of control in patients previously controlled under a stable dose of peg, without any other treatment change. Lipodystrophy was defined as either hypertrophy or atrophy of subcutaneous tissue in areas of drug ...